Serovoxin 50 Tablet
120,00 ₹
Analogs of Serovoxin 50 Tablet
Find cheaper analogs and generic equivalents for Serovoxin 50 Tablet.
Principio activo: Fluvoxamine
Resumen del producto
About Serovoxin 50 Tablet
Serovoxin 50 Tablet is a medication containing the active ingredient Fluvoxamine, classified as SSRI antidepressant. Fluvoxamine, sold under the brand name Luvox among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is primarily used to treat major depressive disorder and, perhaps more especially, obsessive–compulsive disorder (OCD), but is also used to treat anxiety disorders such as.
Key Benefits & Uses
- Used for: 1 INDICATIONS AND USAGE Fluvoxamine maleate extended-release capsules is a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment.
- Used for: Efficacy was demonstrated in: One 12-week study fluvoxamine maleate extended-release capsules in adults ( 14
- Use only as directed on the product label or by a healthcare professional.
Active Ingredient & Action
Fluvoxamine, the active ingredient in Serovoxin 50 Tablet, belongs to the SSRI antidepressant class. 1 INDICATIONS AND USAGE Fluvoxamine maleate extended-release capsules is a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of obsessive compulsive disorder (OCD) ( 1 ). Efficacy was demonstrated in: One 12-week study fluvoxamine maleate extended-release capsules in adults ( 14. 1 ). Inactive ingredients: not listed in source data.
Important Notes
Always read and follow the label instructions carefully before taking Serovoxin 50 Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Serovoxin 50 Tablet for extended periods without medical advice.
Find in Pharmacies
Compare local prices and distance for Serovoxin 50 Tablet.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.